These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10146527)

  • 21. [The role of advanced cardiac imaging methods in coronary artery disease].
    Kiraç S
    Anadolu Kardiyol Derg; 2008 Jul; 8 Suppl 1():1-4. PubMed ID: 18611832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
    Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
    J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine.
    Schelbert HR
    Semin Nucl Med; 1987 Apr; 17(2):145-81. PubMed ID: 3296198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radioisotopic methods of estimating perfusion and viability (metabolism) of the myocardium].
    Budlewski T; Rogowski F
    Przegl Lek; 1997; 54(1):46-51. PubMed ID: 9190635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress.
    Leoncini M; Marcucci G; Sciagrà R; Frascarelli F; Simonetti I; Bini L; Maioli M; Mennuti A; Dabizzi RP
    Am J Cardiol; 2001 Jun; 87(12):1346-50. PubMed ID: 11397351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA; Watson DD
    Semin Nucl Med; 1991 Jul; 21(3):173-81. PubMed ID: 1835136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological stress testing.
    Travain MI; Wexler JP
    Semin Nucl Med; 1999 Oct; 29(4):298-318. PubMed ID: 10534233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of 99mTc-labeled perfusion agents in the simultaneous assessment of myocardial perfusion and cardiac function].
    Ishida Y
    Kaku Igaku; 2002 Feb; 39(1):1-6. PubMed ID: 11915307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging.
    Wu JC; Yun JJ; Heller EN; Dione DP; DeMan P; Liu YH; Zaret BL; Wackers FJ; Sinusas AJ
    J Nucl Med; 1998 Mar; 39(3):417-25. PubMed ID: 9529285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial perfusion imaging in the diagnosis of coronary artery disease.
    Go RT; MacIntyre WJ; Cook SA; Neumann DR
    Curr Opin Radiol; 1992 Aug; 4(4):23-33. PubMed ID: 1627448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of coronary microvascular dysfunction in the genesis of cardiovascular diseases.
    Parodi O; Sambuceti G
    Q J Nucl Med; 1996 Mar; 40(1):9-16. PubMed ID: 8681018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
    Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
    Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function.
    Dakik HA; Howell JF; Lawrie GM; Espada R; Weilbaecher DG; He ZX; Mahmarian JJ; Verani MS
    Circulation; 1997 Nov; 96(9):2892-8. PubMed ID: 9386154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.
    Soufer R; Dey HM; Ng CK; Zaret BL
    Am J Cardiol; 1995 Jun; 75(17):1214-9. PubMed ID: 7778542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99Tcm-SESTAMIBI for planar myocardial perfusion imaging; not as ideal as the physical properties.
    Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
    Nucl Med Commun; 1991 May; 12(5):381-91. PubMed ID: 1829798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technetium Tc 99m sestamibi myocardial perfusion imaging: current role for evaluation of prognosis.
    Mandalapu BP; Amato M; Stratmann HG
    Chest; 1999 Jun; 115(6):1684-94. PubMed ID: 10378569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols.
    Berman DS; Kiat HS; Van Train KF; Germano G; Maddahi J; Friedman JD
    J Nucl Med; 1994 Apr; 35(4):681-8. PubMed ID: 8151394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.